Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis (MTX01)

This study has been completed.
Sponsor:
Collaborators:
Consultants in Neurology
Biogen Idec
Information provided by:
MidAmerica Neuroscience Institute
ClinicalTrials.gov Identifier:
NCT00037102
First received: May 15, 2002
Last updated: June 16, 2009
Last verified: November 2003
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2003
  Estimated Primary Completion Date: No date given